logo

EbookBell.com

Most ebook files are in PDF format, so you can easily read them using various software such as Foxit Reader or directly on the Google Chrome browser.
Some ebook files are released by publishers in other formats such as .awz, .mobi, .epub, .fb2, etc. You may need to install specific software to read these formats on mobile/PC, such as Calibre.

Please read the tutorial at this link:  https://ebookbell.com/faq 


We offer FREE conversion to the popular formats you request; however, this may take some time. Therefore, right after payment, please email us, and we will try to provide the service as quickly as possible.


For some exceptional file formats or broken links (if any), please refrain from opening any disputes. Instead, email us first, and we will try to assist within a maximum of 6 hours.

EbookBell Team

Alternative Splicing and Disease 1st Edition by Philippe Jeanteur ISBN 3642070817 9783642070815

  • SKU: BELL-2162964
Alternative Splicing and Disease 1st Edition by Philippe Jeanteur ISBN 3642070817 9783642070815
$ 31.00 $ 45.00 (-31%)

4.0

86 reviews

Alternative Splicing and Disease 1st Edition by Philippe Jeanteur ISBN 3642070817 9783642070815 instant download after payment.

Publisher: Springer
File Extension: PDF
File size: 2.51 MB
Pages: 264
Author: Philippe Jeanteur (Editor)
ISBN: 9783540344483, 3540344489
Language: English
Year: 2006
Edition: 1

Product desciption

Alternative Splicing and Disease 1st Edition by Philippe Jeanteur ISBN 3642070817 9783642070815 by Philippe Jeanteur (editor) 9783540344483, 3540344489 instant download after payment.

Alternative Splicing and Disease 1st Edition by Philippe Jeanteur - Ebook PDF Instant Download/Delivery: 3642070817, 9783642070815
Full download Alternative Splicing and Disease 1st Edition after payment

Product details:

ISBN 10: 3642070817 
ISBN 13: 9783642070815
Author: Philippe Jeanteur

Splicing of primary RNA transcript, i.e. removal of introns and joining of exons to produce mature mRNAs competent for translation into proteins, is a quasi-systematic step of gene expression in higher organisms. However, this process is not unequivocal but can follow alternate pathways. Alternative splicing of a given transcript can therefore yield several distinct mRNAs encoding as many different proteins. Its full biological significance has not been appreciated until it was recognized that alternative splicing is so general as to affect about 75% of all human genes. Therefore, alternative splicing not only vastly increases protein diversity but also offers numerous opportunities for aberrant splicing events with pathological consequences.

Alternative Splicing and Disease 1st Table of contents:

Part I: Fundamental Mechanisms of Alternative Splicing

  • Chapter 1: The Spliceosome: Architecture, Dynamics, and Catalysis
    • Overview of Pre-mRNA Splicing
    • Composition and Assembly of the Major Spliceosome
    • Minor Spliceosome and Its Unique Features
    • Catalytic Mechanism of Splicing
    • Regulation of Spliceosome Assembly and Function
  • Chapter 2: Cis-Regulatory Elements and Trans-Acting Factors in Alternative Splicing
    • Splicing Enhancers (ESEs, ISEs) and Silencers (ESSs, ISSs)
    • RNA Binding Proteins (RBPs): SR Proteins, hnRNPs, and Others
    • Sequence Motifs and RNA Structure
    • Chromatin Structure and Epigenetic Regulation of Splicing
  • Chapter 3: Modes of Alternative Splicing and Their Functional Diversity
    • Exon Skipping/Inclusion
    • Mutually Exclusive Exons
    • Alternative 5' and 3' Splice Sites
    • Intron Retention
    • Alternative Promoters and Polyadenylation Sites
    • Impact on Protein Isoforms, Localization, and Function

Part II: Methodologies for Studying Alternative Splicing

  • Chapter 4: High-Throughput Approaches to Alternative Splicing Discovery
    • RNA Sequencing (RNA-Seq) and Isoform Quantification
    • Splicing-Sensitive Microarrays
    • CLIP-Seq (Cross-Linking Immunoprecipitation followed by Sequencing)
    • Mass Spectrometry for Proteoform Analysis
  • Chapter 5: Functional Validation and Manipulating Splicing
    • RT-PCR and Quantitative PCR for Isoform Detection
    • Minigene Assays for Splicing Element Characterization
    • CRISPR/Cas9 for Splicing Site and RBP Gene Editing
    • Antisense Oligonucleotides (ASOs) and Splice-Modulating Small Molecules

Part III: Alternative Splicing in Disease Pathogenesis

  • Chapter 6: Alternative Splicing in Cancer
    • Oncogene and Tumor Suppressor Isoforms
    • Splicing Factor Dysregulation in Cancer
    • Specific Examples: CD44, FGFr2, PKM2, BCL-x
    • Splicing as a Driver of Tumorigenesis and Metastasis
  • Chapter 7: Neurological and Neurodegenerative Disorders
    • Alternative Splicing in Brain Development and Function
    • Alzheimer's Disease: APP and Tau Splicing
    • Parkinson's Disease and ALS: SOD1, TDP-43, FUS
    • Spinal Muscular Atrophy (SMA): SMN2 Splicing
    • Autism Spectrum Disorders and Splicing Deregulation
  • Chapter 8: Cardiovascular Diseases
    • Splicing Isoforms in Cardiac Development and Physiology
    • Alternative Splicing in Heart Failure and Arrhythmias
    • Vascular Disease and Endothelial Cell Splicing
    • Channelopathies and Splicing Defects
  • Chapter 9: Metabolic and Autoimmune Diseases
    • Splicing in Diabetes and Insulin Signaling
    • Inflammatory Bowel Disease and Immune System Splicing
    • Rheumatoid Arthritis and Systemic Lupus Erythematosus
  • Chapter 10: Rare Genetic Disorders and Splicing Mutations
    • Splice Site Mutations and Cryptic Splicing
    • Disease-Causing Mutations in Splicing Regulatory Elements
    • Examples: Cystic Fibrosis, Thalassemia, Familial Dysautonomia
    • The Role of Splicing in Orphan Diseases

Part IV: Therapeutic Strategies and Future Directions

  • Chapter 11: Targeting Alternative Splicing for Therapeutic Intervention
    • Antisense Oligonucleotides (ASOs): Current and Emerging Therapies (e.g., Nusinersen for SMA)
    • Small Molecules Modulating Splicing Factors
    • CRISPR-Based Approaches for Splicing Correction
    • Challenges and Opportunities in Drug Development
  • Chapter 12: Biomarkers and Diagnostics Based on Alternative Splicing
    • Splicing Isoforms as Diagnostic Markers
    • Prognostic and Predictive Biomarkers in Cancer
    • Liquid Biopsies and Splicing-Derived Exosomes
  • Chapter 13: Emerging Concepts and Future Outlook
    • Circular RNAs and Their Regulatory Roles
    • RNA Modifications (Epitranscriptomics) and Splicing
    • Single-Cell RNA-Seq for Splicing Heterogeneity
    • Computational Prediction of Splicing Events and Disease Linkages
    • The Promise of Personalized Medicine Through Splicing Modulation

People also search for Alternative Splicing and Disease 1st:

alternative splicing and disease
    
alternative splicing and isoforms from mechanisms to diseases
    
alternative splicing and cardiovascular disease
    
alternative splicing isoforms in health and disease
    
alternative splicing example

 

Tags: Philippe Jeanteur, Alternative, Splicing

Related Products